Jennifer J Rhodes
CIK 1568249 · EVP, CHIEF LEGAL OFFICER, SEC · last filed 2026-03-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$319.0K
Companies
4
Total Filings
43
Lifetime Open-Market Net
-$2.44M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACAD | EVP, CHIEF LEGAL OFFICER, SEC | 15,124 | $21.09 | $319.0K | -$245.0K | 5 | 2026-03-26 |
| Elicio Therapeutics, Inc. (ANGN) Delisted | See Remarks | 30,399 | $10.00 | $304.0K | -$62.4K | 15 | 2022-03-04 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | CBO, GC & Compliance Officer | 63,114 | $8.22 | $518.8K | -$106.0K | 13 | 2019-06-21 |
| MEDIVATION, INC. (MDVN) Delisted | GC & Corporate Secretary | 11,090 | — | — | -$2.03M | 10 | 2015-03-17 |
Recent Filings · Page 2 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-17 | Elicio Therapeutics, Inc. (ANGN) Delisted | Sell (S) | −445 | -$4.8K | EDGAR |
| 2021-07-22 | Elicio Therapeutics, Inc. (ANGN) Delisted | Sell (S) | −432 | -$4.7K | EDGAR |
| 2021-07-20 | Elicio Therapeutics, Inc. (ANGN) Delisted | — | — | $0 | EDGAR |
| 2021-07-15 | Elicio Therapeutics, Inc. (ANGN) Delisted | Sell (S) | −431 | -$4.7K | EDGAR |
| 2021-06-16 | Elicio Therapeutics, Inc. (ANGN) Delisted | Sell (S) | −427 | -$5.7K | EDGAR |
| 2021-05-18 | Elicio Therapeutics, Inc. (ANGN) Delisted | Sell (S) | −440 | -$6.1K | EDGAR |
| 2021-04-15 | Elicio Therapeutics, Inc. (ANGN) Delisted | Sell (S) | −399 | -$6.0K | EDGAR |
| 2021-03-16 | Elicio Therapeutics, Inc. (ANGN) Delisted | Sell (S) | −499 | -$10.2K | EDGAR |
| 2021-02-17 | Elicio Therapeutics, Inc. (ANGN) Delisted | Sell (S) | −457 | -$8.9K | EDGAR |
| 2021-02-08 | Elicio Therapeutics, Inc. (ANGN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.